Omalizumab is effective in treating severe asthma in patients with severe cardiovascular complications and its effects on sCD200, d-dimer, CXCL8, 25-hydroxyvitamin D and IL-1 beta levels


Yalcin A. D., ÇİLLİ A., Bisgin A., Strauss L. G., Herth F.

EXPERT OPINION ON BIOLOGICAL THERAPY, vol.13, no.9, pp.1335-1341, 2013 (SCI-Expanded) identifier identifier identifier

Abstract

Background: There have been concerns about the cardiovascular safety of omalizumab.